Literature DB >> 6374086

The lyophilization of pharmaceuticals: a literature review.

N A Williams, G P Polli.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6374086

Source DB:  PubMed          Journal:  J Parenter Sci Technol        ISSN： 0279-7976


× No keyword cloud information.
  6 in total

1.  Pharmaceutical development of a parenteral lyophilized formulation of the novel indoloquinone antitumor agent EO9.

Authors:  J D Jonkman-de Vries; H Talsma; R E Henrar; J J Kettenes-van den Bosch; A Bult; J H Beijnen
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  A mucoadhesive patch loaded with freeze-dried liposomes for the local treatment of oral tumors.

Authors:  Layan Habib; Mohammed Alyan; Yasmine Ghantous; Jeny Shklover; Janna Shainsky; Imad Abu El-Naaj; Havazelet Bianco-Peled; Avi Schroeder
Journal:  Drug Deliv Transl Res       Date:  2022-09-01       Impact factor: 5.671

3.  Hygroscopicity of cefazolin sodium: application to evaluate the crystallinity of freeze-dried products.

Authors:  T Osawa; M S Kamat; P P DeLuca
Journal:  Pharm Res       Date:  1988-07       Impact factor: 4.200

4.  Effect of the Freezing Step in the Stability and Bioactivity of Protein-Loaded PLGA Nanoparticles Upon Lyophilization.

Authors:  Pedro Fonte; Fernanda Andrade; Cláudia Azevedo; João Pinto; Vítor Seabra; Marco van de Weert; Salette Reis; Bruno Sarmento
Journal:  Pharm Res       Date:  2016-07-21       Impact factor: 4.200

5.  Formation of zinc-peptide spherical microparticles during lyophilization from tert-butyl alcohol/water co-solvent system.

Authors:  Feng Qian; Nina Ni; Jia-Wen Chen; Sridhar Desikan; Vijay Naringrekar; Munir A Hussain; Nancy P Barbour; Ronald L Smith
Journal:  Pharm Res       Date:  2008-06-14       Impact factor: 4.200

6.  Reconstitution properties of biologically active polymersomes after cryogenic freezing and a freeze-drying process.

Authors:  Robert Ccorahua; Silvia Moreno; Hannes Gumz; Karin Sahre; Brigitte Voit; Dietmar Appelhans
Journal:  RSC Adv       Date:  2018-07-17       Impact factor: 3.361
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.